Martin Shkreli, the 32-year-old chief executive of Turing Pharmaceuticals who gained infamy for jacking up the price of a life-saving drug to $750 a dose, from $13.50, has been arrested on suspicion that he illegally siphoned shares from a biotech firm he founded to pay for unrelated debts, Bloomberg reported Thursday morning. Update: Reuters confirmed that FBI agents arrested Shkreli early Thursday; he was wearing a hoodie as he was escorted from his Midtown Manhattan apartment tower.
Shkreli was ousted from the earlier firm he started, Retrophin Inc., in 2014, and the board of that company has sued him, accusing him of misappropriating money from Retrophin to pay off investors in his defunct hedge fund, MSMB Capital Management. The Securities and Exchange Commission is expected to file a civil suit against Shkreli that hews closely to the federal criminal case.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Markets notch worst quarter in years as new tariffs loomSpeed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
-
Tesla Cybertrucks recalled over dislodging panelsSpeed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
-
Crafting emporium Joann is going out of businessSpeed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
-
Trump's China tariffs start after Canada, Mexico pausesSpeed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
-
Chinese AI chatbot's rise slams US tech stocksSpeed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
-
US port strike averted with tentative labor dealSpeed Read The strike could have shut down major ports from Texas to Maine
-
Biden expected to block Japanese bid for US SteelSpeed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
-
Judges block $25B Kroger-Albertsons mergerSpeed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
